pancreas_largePancreas is the official journal of the American Pancreatic Association. Pancreas provides a central forum for communication of original works involving both basic and clinical research on the exocrine and endocrine pancreas and their interrelationships and consequences in disease states. This multidisciplinary, international journal covers the whole spectrum of basic sciences, etiology, prevention, pathophysiology, diagnosis, and surgical and medical management of pancreatic diseases, including cancer.

APA Members receive free online access to Pancreas and discounted subscription rates for the hard copy of the journal.


 pancreapedia logo 220px widePancreapedia is an open access, on-line, knowledge base relating to the exocrine pancreas that is sponsored by the American Pancreatic Association.  It includes up to date citable reviews, methods articles as well as containing a worldwide directory of pancreatologists.  APA members are invited to both find and contribute information to the Pancreapedia. Please register and add yourself and your interests to the Directory.


Presented by Kenner Family Research Fund (KFRF)

in Partnership with the

American Pancreatic Association (APA)

Thursday, October 27, 4:30-6:45 pm


Early Detection of Pancreatic Cancer: The Role of industry in the Development of Biomarkers provides a unique and exciting opportunity to increase awareness of industry’s role in the development of biomarkers. Presentations include:

Current State of Biomarkers

Sudhir Srivastava, PhD, PMH, MS, Chief, Cancer Biomarkers Research Group

National Cancer Institute



Anne-Renee Hartman, MD, Medical Director and Director of Clinical Product Development



Christer Wingren, PhD, Chief Technology Officer

Laura Chirica, PhD, Chief Commercial Officer


Project Survival

Niven R. Narain, MD, Co-founder, President and CEO, Berg

A. James Moser, MD FACS, Co-Director, Pancreas and Liver Institute

Beth Israel Deaconess Medical Center


Following the presentations, a conversation between the distinguished panelists and the audience will be facilitated by Suresh T. Chari, MD, Director of the Pancreas Clinic at Mayo Clinic and Anirban Maitra, MBBS, Scientific Director of the Sheikh Ahmed Bin Zayed Center for Pancreas Cancer Research at MD Anderson Cancer Center.

This Forum is a next step in the strategic plan initially set forth at the 2014 Early Detection of Sporadic Pancreatic Cancer Summit Conference presented by KFRF in partnership with the APA which provided a foundation for the field (“Early Detection of Sporadic Pancreatic Cancer: Summative Review.” Pancreas July 2015 - Volume 44 - Issue 5 - p 693–712) and led to the creation of a defined pathway for the future

(“Early Detection of Sporadic Pancreatic Cancer: Strategic Map for Innovation—A White Paper.” Pancreas July 2015 - Volume 44 - Issue 5 - p 686–692).

The 2015 Forum, Early Detection: Lessons Learned from Other Cancers, provided historical perspective on the critical barriers to achieving progress in breast, prostate and colon cancers and how this knowledge could be applied to the early detection of pancreatic cancer (“Early Detection of Pancreatic Cancer—a Defined Future Using Lessons From Other Cancers: A White Paper.” Pancreas September 2016 - Volume 45 - Issue 8 - p 1073–1079).


Kenner Family Research Fund, a registered 501(c) 3 organization, is committed to investing in initiatives to establish an early detection protocol for pancreatic cancer. The fund was formed by family and friends in memory of Peter Kenner.